Perrine Soret

Gif-sur-yvette, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease.

Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease.

Journal: Annals of the rheumatic diseases

Published: September 24, 2025

Multi-omic analysis identifies biological processes underlying progressive interstitial lung disease in systemic sclerosis.

Multi-omic analysis identifies biological processes underlying progressive interstitial lung disease in systemic sclerosis.

Journal: The FEBS journal

Published: July 10, 2024

Virtual patients inspired by multiomics predict the efficacy of an anti-IFNα mAb in cutaneous lupus.

Virtual patients inspired by multiomics predict the efficacy of an anti-IFNα mAb in cutaneous lupus.

Journal: iScience

Published: April 12, 2024

Serum ARGS-aggrecan in a phase 2 clinical trial targeting osteoarthritis.

Serum ARGS-aggrecan in a phase 2 clinical trial targeting osteoarthritis.

Journal: Osteoarthritis and cartilage

Published: December 20, 2023

High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren's syndrome.

High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren's syndrome.

Journal: Journal of autoimmunity

Published: September 25, 2023

Consensus gene modules strategy identifies candidate blood-based biomarkers for primary Sjögren's disease.

Consensus gene modules strategy identifies candidate blood-based biomarkers for primary Sjögren's disease.

Journal: Clinical immunology (Orlando, Fla.)

Published: August 18, 2023

Antibody-mediated neutralization of galectin-3 as a strategy for the treatment of systemic sclerosis.

Antibody-mediated neutralization of galectin-3 as a strategy for the treatment of systemic sclerosis.

Journal: Nature communications

Published: October 28, 2022

Sjögren's syndrome: Towards precision medicine

Sjögren's syndrome: Towards precision medicine

Journal: Medecine sciences : M/S

Published: February 18, 2022

Model-based computational precision medicine to develop combination therapies for autoimmune diseases.

Model-based computational precision medicine to develop combination therapies for autoimmune diseases.

Journal: Expert review of clinical immunology

Published: November 29, 2021

New Insights in Microbial Species Predicting Lung Function Decline in CF: Lessons from the MucoFong Project.

New Insights in Microbial Species Predicting Lung Function Decline in CF: Lessons from the MucoFong Project.

Journal: Journal of clinical medicine

Published: June 21, 2021

Network-based repurposing identifies anti-alarmins as drug candidates to control severe lung inflammation in COVID-19.

Network-based repurposing identifies anti-alarmins as drug candidates to control severe lung inflammation in COVID-19.

Journal: PloS one

Published: March 05, 2021

A new molecular classification to drive precision treatment strategies in primary Sjögren's syndrome.

A new molecular classification to drive precision treatment strategies in primary Sjögren's syndrome.

Journal: Nature communications

Published: November 02, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026